Toll Free: 1-888-928-9744

Abiogen Pharma S.p.A. - Product Pipeline Review - 2015

Published: Mar, 2015 | Pages: 23 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Abiogen Pharma S.p.A. - Product Pipeline Review - 2015

Summary

Global Markets Direct's, 'Abiogen Pharma S.p.A. - Product Pipeline Review - 2015', provides an overview of the Abiogen Pharma S.p.A.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Abiogen Pharma S.p.A.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Abiogen Pharma S.p.A. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Abiogen Pharma S.p.A.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Abiogen Pharma S.p.A.'s pipeline products

Reasons To Buy

- Evaluate Abiogen Pharma S.p.A.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Abiogen Pharma S.p.A. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Abiogen Pharma S.p.A.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Abiogen Pharma S.p.A. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Abiogen Pharma S.p.A.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
- Explore the dormant and discontinued projects of Abiogen Pharma S.p.A. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Abiogen Pharma S.p.A. Snapshot 4
Abiogen Pharma S.p.A. Overview 4
Key Information 4
Key Facts 4
Abiogen Pharma S.p.A. - Research and Development Overview 5
Key Therapeutic Areas 5
Abiogen Pharma S.p.A. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Pipeline Products - Combination Treatment Modalities 9
Abiogen Pharma S.p.A. - Pipeline Products Glance 10
Abiogen Pharma S.p.A. - Late Stage Pipeline Products 10
Phase III Products/Combination Treatment Modalities 10
Abiogen Pharma S.p.A. - Clinical Stage Pipeline Products 11
Phase I Products/Combination Treatment Modalities 11
Abiogen Pharma S.p.A. - Drug Profiles 12
clodronate disodium 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
neridronic acid 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
(clodronate disodium + hyaluronic acid) 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Abiogen Pharma S.p.A. - Pipeline Analysis 15
Abiogen Pharma S.p.A. - Pipeline Products by Target 15
Abiogen Pharma S.p.A. - Pipeline Products by Route of Administration 16
Abiogen Pharma S.p.A. - Pipeline Products by Molecule Type 17
Abiogen Pharma S.p.A. - Pipeline Products by Mechanism of Action 18
Abiogen Pharma S.p.A. - Recent Pipeline Updates 19
Abiogen Pharma S.p.A. - Dormant Projects 20
Abiogen Pharma S.p.A. - Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
Coverage 22
Secondary Research 22
Primary Research 22
Expert Panel Validation 22
Contact Us 22
Disclaimer 23
List of Tables
Abiogen Pharma S.p.A., Key Information 4
Abiogen Pharma S.p.A., Key Facts 4
Abiogen Pharma S.p.A. - Pipeline by Indication, 2015 6
Abiogen Pharma S.p.A. - Pipeline by Stage of Development, 2015 7
Abiogen Pharma S.p.A. - Monotherapy Products in Pipeline, 2015 8
Abiogen Pharma S.p.A. - Combination Treatment Modalities in Pipeline, 2015 9
Abiogen Pharma S.p.A. - Phase III, 2015 10
Abiogen Pharma S.p.A. - Phase I, 2015 11
Abiogen Pharma S.p.A. - Pipeline by Target, 2015 15
Abiogen Pharma S.p.A. - Pipeline by Route of Administration, 2015 16
Abiogen Pharma S.p.A. - Pipeline by Molecule Type, 2015 17
Abiogen Pharma S.p.A. - Pipeline Products by Mechanism of Action, 2015 18
Abiogen Pharma S.p.A. - Recent Pipeline Updates, 2015 19
Abiogen Pharma S.p.A. - Dormant Developmental Projects,2015 20 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify